Genomics in Drug Discovery and DevelopmentISBN: 978-0-470-09604-8
Hardcover
496 pages
November 2008
![]() Other Available Formats: E-book
|
Early characterization of toxicity and efficacy would significantly
impact the overall productivity of pharmaceutical R&D and
reduce drug candidate attrition and failure. By describing the
available platforms and weighing their relative advantages and
disadvantages, including microarray data analysis, Genomics in Drug
Discovery and Development introduces readers to the biomarker,
pharmacogenomic, and toxicogenomics toolbox. The authors provide a
valuable resource for pharmaceutical discovery scientists,
preclinical drug safety department personnel, regulatory personnel,
discovery toxicologists, and safety scientists, drug development
professionals, and pharmaceutical scientists.